Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/188787
COMPARTIR / EXPORTAR:
logo share SHARE logo core CORE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE

Invitar a revisión por pares abierta
Título

HIF1α suppresses tumor cell proliferation through inhibition of aspartate biosynthesis

AutorMeléndez-Rodríguez, Florinda; Urrutia, Andrés A.; Lorendeau, Doriane; Rinaldi, Gianmarco; Roche, Olga CSIC ORCID; Böğürcü-Seidel, Nuray; Ortega-Muelas, Marta; Mesa-Ciller, Claudia; Turiel, Guillermo; Bouthelier, Antonio; Hernansanz-Agustín, Pablo; Elorza, Ainara; Escasany, Elia; Yang Li, Qilong Oscar; Torres-Capelli, Mar; Tello, Daniel; Fuertes, Esther; Fraga, Enrique; Martínez-Ruiz, Antonio CSIC ORCID; Pérez, Belén CSIC ORCID; Giménez-Bachs, José M.; Salinas-Sánchez, Antonio S.; Acker, Till; Sánchez-Prieto, Ricardo CSIC ORCID; Fendt, Sarah-Maria; De Bock, Katrien; Aragonés, Julián
Palabras claveHIF1α
Glutamine
Aspartate biosynthesis
GOT1
GOT2
Cancer
Proliferation
Oxygen
Renal cell carcinoma
Fecha de publicación2019
EditorElsevier
CitaciónCell Reports 26(9): 2257-2265.e4
ResumenCellular aspartate drives cancer cell proliferation, but signaling pathways that rewire aspartate biosynthesis to control cell growth remain largely unknown. Hypoxia-inducible factor-1α (HIF1α) can suppress tumor cell proliferation. Here, we discovered that HIF1α acts as a direct repressor of aspartate biosynthesis involving the suppression of several key aspartate-producing proteins, including cytosolic glutamic-oxaloacetic transaminase-1 (GOT1) and mitochondrial GOT2. Accordingly, HIF1α suppresses aspartate production from both glutamine oxidation as well as the glutamine reductive pathway. Strikingly, the addition of aspartate to the culture medium is sufficient to relieve HIF1α-dependent repression of tumor cell proliferation. Furthermore, these key aspartate-producing players are specifically repressed in VHL-deficient human renal carcinomas, a paradigmatic tumor type in which HIF1α acts as a tumor suppressor, highlighting the in vivo relevance of these findings. In conclusion, we show that HIF1α inhibits cytosolic and mitochondrial aspartate biosynthesis and that this mechanism is the molecular basis for HIF1α tumor suppressor activity.
Versión del editorhttps://doi.org/10.1016/j.celrep.2019.01.106
URIhttp://hdl.handle.net/10261/188787
DOI10.1016/j.celrep.2019.01.106
E-ISSN2211-1247
Aparece en las colecciones: (IIBM) Artículos
(CBM) Artículos




Ficheros en este ítem:
Fichero Descripción Tamaño Formato
hifbio.pdf2,18 MBAdobe PDFVista previa
Visualizar/Abrir
Mostrar el registro completo

CORE Recommender

PubMed Central
Citations

38
checked on 08-feb-2024

SCOPUSTM   
Citations

52
checked on 15-mar-2024

WEB OF SCIENCETM
Citations

49
checked on 28-feb-2024

Page view(s)

251
checked on 18-mar-2024

Download(s)

187
checked on 18-mar-2024

Google ScholarTM

Check

Altmetric

Altmetric


Artículos relacionados:


NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.